Compare BridgeBio Pharma Inc (BBIO) vs Cognizant Technology Solutions Corp (CTSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Cognizant Technology Solutions Corp — how do they compare? BridgeBio Pharma Inc trades at $84.09 (market cap $16.27B), while Cognizant Technology Solutions Corp trades at $43.32 (market cap $20.89B). The key difference: Cognizant Technology Solutions Corp is the larger of the two by market cap, and Cognizant Technology Solutions Corp pays a 2.99% dividend while BridgeBio Pharma Inc pays none. Which is the better fit depends on your goals.
| BBIO | CTSH | |
|---|---|---|
Market Cap | $16.27B | $20.89B |
Sector | Health | Technology |
52-Week High | $90.17 | $86.70 |
52-Week Low | $44.81 | $38.73 |
Enterprise Value | $17.82B | $20.46B |
Dividend Yield | — | 2.99% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Cognizant Technology Solutions Corp
Cognizant is a global IT services provider, offering consulting and outsourcing services to some of the world's largest enterprises spanning the financial services, media and communications, healthcare, natural resources, and consumer products industries. Cognizant employs nearly 300,000 people globally, roughly 70% of whom are in India, although the company's headquarters are in Teaneck, New Jersey.
Read more on CTSH →
